Sestrin2 decreases renal oxidative stress, lowers blood pressure, and mediates dopamine D2 receptor-induced inhibition of reactive oxygen species production

Hypertension

Volumn 64, Issue 4, 2014, Pages 825-832

  Yang, Yu ^a   Cuevas, Santiago ^a   Yang, Sufei ^a   Villar, Van Anthony ^a   Escano, Crisanto ^a   Asico, Laureano ^a   Yu, Peiying ^a   Jiang, Xiaoliang ^a   Weinman, Edward J ^a   Armando, Ines ^a   Jose, Pedro A ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Aryldialkylphosphatase; Dopamine D2; Hypertension; Peroxiredoxins; Reactive oxygen species; Receptors

Indexed keywords

ARYLDIALKYLPHOSPHATASE; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; NUCLEAR PROTEIN; PEROXIREDOXIN; PON2 PROTEIN, HUMAN; QUINPIROLE; REACTIVE OXYGEN METABOLITE; SESN2 PROTEIN, HUMAN; SESTRIN 2 PROTEIN, MOUSE;

129 MOUSE; AGONISTS; ANIMAL; BLOOD PRESSURE; C57BL MOUSE; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; GENETICS; HUMAN; IMMUNOBLOTTING; KIDNEY; KIDNEY PROXIMAL TUBULE; KNOCKOUT MOUSE; METABOLISM; MOUSE; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PHYSIOLOGY; RNA INTERFERENCE; UPREGULATION;

ANIMALS; ARYLDIALKYLPHOSPHATASE; BLOOD PRESSURE; CELLS, CULTURED; DOPAMINE AGONISTS; HUMANS; IMMUNOBLOTTING; KIDNEY; KIDNEY TUBULES, PROXIMAL; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; NUCLEAR PROTEINS; OXIDATION-REDUCTION; OXIDATIVE STRESS; PEROXIREDOXINS; QUINPIROLE; REACTIVE OXYGEN SPECIES; RECEPTORS, DOPAMINE D2; RNA INTERFERENCE; UP-REGULATION;

EID: 84914670981     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.114.03840     Document Type: Article

References (38)

1. Hussain T, Lokhandwala MF. Renal dopamine receptors and hypertension. Exp Biol Med (Maywood). 2003;228: 134-142.
2. Zeng C, Sanada H, Watanabe H, Eisner GM, Felder RA, Jose PA. Functional genomics of the dopaminergic system in hypertension. Physiol Genomics. 2004;19: 233-246.
3. Harris RC, Zhang MZ. Dopamine, the kidney, and hypertension. Curr Hypertens Rep. 2012;14: 138-143.
4. Bek MJ, Wang X, Asico LD, Jones JE, Zheng S, Li X, Eisner GM, Grandy DK, Carey RM, Soares-da-Silva P, Jose PA. Angiotensin-II type 1 receptor-mediated hypertension in D4 dopamine receptor-deficient mice. Hypertension. 2006;47: 288-295.
5. Li XX, Bek M, Asico LD, Yang Z, Grandy DK, Goldstein DS, Rubinstein M, Eisner GM, Jose PA. Adrenergic and endothelin B receptor-dependent hypertension in dopamine receptor type-2 knockout mice. Hypertension. 2001;38: 303-308.
6. Ueda A, Ozono R, Oshima T, Yano A, Kambe M, Teranishi Y, Katsuki M, Chayama K. Disruption of the type 2 dopamine receptor gene causes a sodium-dependent increase in blood pressure in mice. Am J Hypertens. 2003;16: 853-858.
7. Rosmond R, Rankinen T, Chagnon M, Pérusse L, Chagnon YC, Bouchard C, Björntorp P. Polymorphism in exon 6 of the dopamine D(2) receptor gene (DRD2) is associated with elevated blood pressure and personality disorders in men. J Hum Hypertens. 2001;15: 553-558.
8. Thomas GN, Tomlinson B, Critchley JA. Modulation of blood pressure and obesity with the dopamine D2 receptor gene TaqI polymorphism. Hypertension. 2000;36: 177-182.
9. Harrison DG, Gongora MC. Oxidative stress and hypertension. Med Clin North Am. 2009;93: 621-635.
10. Lu Q, Yang Y, Villar VA, Asico L, Jones JE, Yu P, Li H, Weinman EJ, Eisner GM, Jose PA. D5 dopamine receptor decreases NADPH oxidase, reactive oxygen species and blood pressure via heme oxygenase-1. Hypertens Res. 2013;36: 684-690.
11. Briones AM, Touyz RM. Oxidative stress and hypertension: Current concepts. Curr Hypertens Rep. 2010;12: 135-142.
12. Armando I, Wang X, Villar VA, Jones JE, Asico LD, Escano C, Jose PA. Reactive oxygen species-dependent hypertension in dopamine D2 receptor- deficient mice. Hypertension. 2007;49: 672-678.
13. Horke S, Witte I, Wilgenbus P, Krüger M, Strand D, Förstermann U. Paraoxonase-2 reduces oxidative stress in vascular cells and decreases endoplasmic reticulum stress-induced caspase activation. Circulation. 2007;115: 2055-2064.
14. Cuevas S, Villar VA, Jose PA, Armando I. Renal dopamine receptors, oxidative stress, and hypertension. Int J Mol Sci. 2013;14: 17553-17572.
15. Yang Y, Zhang Y, Cuevas S, Villar VA, Escano C, D Asico L, Yu P, Grandy DK, Felder RA, Armando I, Jose PA. Paraoxonase 2 decreases renal reactive oxygen species production, lowers blood pressure, and mediates dopamine D2 receptor-induced inhibition of NADPH oxidase. Free Radic Biol Med. 2012;53: 437-446.
16. Jönsson TJ, Lowther WT. The peroxiredoxin repair proteins. Subcell Biochem. 2007;44: 115-141.
17. Woo HA, Chae HZ, Hwang SC, Yang KS, Kang SW, Kim K, Rhee SG. Reversing the inactivation of peroxiredoxins caused by cysteine sulfinic acid formation. Science. 2003;300: 653-656.
18. Budanov AV, Sablina AA, Feinstein E, Koonin EV, Chumakov PM. Regeneration of peroxiredoxins by p53-regulated sestrins, homologs of bacterial AhpD. Science. 2004;304: 596-600.
19. Thamsen M, Kumsta C, Li F, Jakob U. Is overoxidation of peroxiredoxin physiologically significant? Antioxid Redox Signal. 2011;14: 725-730.
20. Budanov AV, Shoshani T, Faerman A, Zelin E, Kamer I, Kalinski H, Gorodin S, Fishman A, Chajut A, Einat P, Skaliter R, Gudkov AV, Chumakov PM, Feinstein E. Identification of a novel stress-responsive gene Hi95 involved in regulation of cell viability. Oncogene. 2002;21: 6017-6031.
21. Soriano FX, Papadia S, Bell KF, Hardingham GE. Role of histone acetylation in the activity-dependent regulation of sulfiredoxin and sestrin 2. Epigenetics. 2009;4: 152-158.
22. Liu SY, Lee YJ, Lee TC. Association of platelet-derived growth factor receptor ß accumulation with increased oxidative stress and cellular injury in sestrin 2 silenced human glioblastoma cells. FEBS Lett. 2011;585: 1853-1858.
23. Essler S, Dehne N, Brüne B. Role of sestrin2 in peroxide signaling in macrophages. FEBS Lett. 2009;583: 3531-3535.
24. Papadia S, Soriano FX, Léveillé F, et al. Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses. Nat Neurosci. 2008;11: 476-487.
25. Iida M, Miyazaki I, Tanaka K, Kabuto H, Iwata-Ichikawa E, Ogawa N. Dopamine D2 receptor-mediated antioxidant and neuroprotective effects of ropinirole, a dopamine agonist. Brain Res. 1999;838: 51-59.
26. Cuevas S, Zhang Y, Yang Y, Escano C, Asico L, Jones JE, Armando I, Jose PA. Role of renal DJ-1 in the pathogenesis of hypertension associated with increased reactive oxygen species production. Hypertension. 2012;59: 446-452.
27. Zhang Y, Cuevas S, Asico LD, Escano C, Yang Y, Pascua AM, Wang X, Jones JE, Grandy D, Eisner G, Jose PA, Armando I. Deficient dopamine D2 receptor function causes renal inflammation independently of high blood pressure. PLoS One. 2012;7: E38745.
28. Villar VA, Armando I, Sanada H, Frazer LC, Russo CM, Notario PM, Lee H, Comisky L, Russell HA, Yang Y, Jurgens JA, Jose PA, Jones JE. Novel role of sorting nexin 5 in renal D(1) dopamine receptor trafficking and function: Implications for hypertension. FASEB J. 2013;27: 1808-1819.
29. Bell KF, Hardingham GE. CNS peroxiredoxins and their regulation in health and disease. Antioxid Redox Signal. 2011;14: 1467-1477.
30. Spindel ON, World C, Berk BC. Thioredoxin interacting protein: Redox dependent and independent regulatory mechanisms. Antioxid Redox Signal. 2012;16: 587-596.
31. Hagenbuchner J, Kuznetsov A, Hermann M, Hausott B, Obexer P, Ausserlechner MJ. FOXO3-induced reactive oxygen species are regulated by BCL2L11 (Bim) and SESN3. J Cell Sci. 2012;125(Pt 5): 1191-1203.
32. Lecker SH, Goldberg AL, Mitch WE. Protein degradation by the ubiquitin- proteasome pathway in normal and disease states. J Am Soc Nephrol. 2006;17: 1807-1819.
33. Nistala R, Whaley-Connell A, Sowers JR. Redox control of renal function and hypertension. Antioxid Redox Signal. 2008;10: 2047-2089.
34. Woo HA, Bae SH, Park S, Rhee SG. Sestrin 2 is not a reductase for cysteine sulfinic acid of peroxiredoxins. Antioxid Redox Signal. 2009;11: 739-745.
35. Chevallet M, Wagner E, Luche S, van Dorsselaer A, Leize-Wagner E, Rabilloud T. Regeneration of peroxiredoxins during recovery after oxidative stress: Only some overoxidized peroxiredoxins can be reduced during recovery after oxidative stress. J Biol Chem. 2003;278: 37146-37153.
36. Diet A, Abbas K, Bouton C, Guillon B, Tomasello F, Fourquet S, Toledano MB, Drapier JC. Regulation of peroxiredoxins by nitric oxide in immunostimulated macrophages. J Biol Chem. 2007;282: 36199-36205.
37. Lee JH, Budanov AV, Park EJ, Birse R, Kim TE, Perkins GA, Ocorr K, Ellisman MH, Bodmer R, Bier E, Karin M. Sestrin as a feedback inhibitor of TOR that prevents age-related pathologies. Science. 2010;327: 1223-1228.
38. Budanov AV, Karin M. p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling. Cell. 2008;134: 451-460.